88.80
price up icon3.04%   2.6703
 
loading

Finanzdaten der Arcellx Inc-Aktie (ACLX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.07%
7.554
8.129 26.03 27.38 39.26
Operating Expenses
13.95%
66.28
77.03 59.65 62.38 55.07
Benefits Costs and Expenses
14.35%
60.30
70.40 51.67 54.24 46.45
Costs And Expenses
14.35%
60.30
70.40 51.67 54.24 46.45
Operating Income/Loss
14.76%
-58.73
-68.90 -33.62 -34.99 -15.81
Income/Loss From Continuing Operations Before Tax
15.30%
-52.74
-62.27 -25.64 -26.86 -7.198
Income Tax Expense/Benefit
0.029
- 0.223 0.341 -
Income/Loss From Continuing Operations After Tax
15.25%
-52.77
-62.27 -25.87 -27.20 -7.198
Net Income/Loss
15.25%
-52.77
-62.27 -25.87 -27.20 -7.198
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.75%
56.22
55.26 53.82 53.52 52.76
Diluted Average Shares
1.75%
56.22
55.26 53.82 53.52 52.76
Basic Earnings Per Share
16.81%
-0.94
-1.13 -0.48 -0.51 -0.14
Diluted Earnings Per Share
16.81%
-0.94
-1.13 -0.48 -0.51 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.76
price up icon 1.09%
$28.91
price up icon 0.72%
$102.30
price up icon 0.64%
$104.01
price up icon 0.05%
biotechnology ONC
$310.20
price down icon 0.46%
$183.65
price down icon 1.35%
Kapitalisierung:     |  Volumen (24h):